Tags : business

STADA Acquires GSK’s Consumer Healthcare Portfolio to Expand its OTC

Shots: STADA to acquire GSK’s 15 well-established consumer healthcare brands including Venoruton, for venous treatment, Coldrex cold remedy, Cetebe vitamin C supplements, Mebucaine sore throat range and Tavegyl allergy brand The acquisition will strengthen STADA’s OTC portfolio and accelerates its growth in European countries. The transaction is expected to be completed in Q2’2020 The acquisition […]Read More

Zentiva to Acquire Alvogen’s Generics and OTC Business in Central

Shots: Zentiva acquires Alvogen’s CEE market consisting of 200+ generics and OTC therapies across multiple therapeutics areas which include brands like Lactacyd, Persen, EuBiotic. The transaction is expected to be closed in Q1’20 The focus of the acquisition is to combine two leading branded generics and OTC business in the CEE region and will strengthen […]Read More

Elanco To Acquire Bayer’s Animal Health Business for $7.6B

Shots: Elanco acquires Bayer’s animal health business in cash & stock transaction, making a total deal value $7.6B. Bayer to get $5.32B cash as up front and $2.28B/~68M as Elanco’s common share with the expected closure of transaction in mid-2020 The focus of the acquisition is to strengthen & accelerating Elanco’s IPP strategy through a […]Read More

Perrigo to Separate its Prescription Pharmaceutical Business

Shots:   Perrigo’s separated business helps it to lead the main focus on consumer business, which includes generic medicines including topical creams, foams, mousses, gels, liquids and inhalable products   It may include a tax-efficient separation to shareholders, a sale or merger with no assurance as to form and timing of transaction This separation of […]Read More